fluticasone propionate
PolandDrugs containing this active substance
-
The medicine is used for the prevention of bronchial asthma in adults (mild, moderate, or severe) and in children who require preventive medication.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production Glaxo Wellcome S.A.
-
The medicine is used to prevent asthma attacks in adults and children over 16 years of age, as well as in the treatment of chronic obstructive pulmonary disease (COPD).
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production Glaxo Wellcome S.A.
-
The medicinal product is used for the prevention of severe bronchial asthma in adults and adolescents over 16 years of age. In children aged 4 to 16 years, it is used to treat exacerbations of bronchial asthma.
Form: suspension for nebulization
Active substance Dosage fluticasone propionate 2 mg ATC: R03BA05
Manufacturer: GlaxoSmithKline Trading Services Limited
-
The medicine is used for the prevention of severe bronchial asthma in adults and adolescents over 16 years of age. In children aged 4 to 16 years, it is used to treat exacerbations of bronchial asthma.
Form: suspension for nebulization
Active substance Dosage fluticasone propionate 0.5 mg ATC: R03BA05
Manufacturer: GlaxoSmithKline Trading Services Limited
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Form: powder for inhalation
Active substance Dosage fluticasone propionate 50 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also indicated for the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg ATC: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to reduce swelling and irritation in the lungs. It is prescribed for asthma (in adults and adolescents over 16 years of age) and for chronic obstructive pulmonary disease (COPD) in adults.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 micrograms ATC: R03BA05
Manufacturer: Cipla Europe NV Glenmark Pharmaceuticals s.r.o. S&D Pharma CZ, spol. s r.o.
-
Flurhinal is used for the treatment of asthma in adults and adolescents over 16 years of age, as well as for the treatment of chronic obstructive pulmonary disease (COPD) in adults (in which case it is used together with other bronchodilators). It works by reducing swelling and irritation in the lungs.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate No input provided ATC: R03BA05
Manufacturer: Cipla Europe NV Glenmark Pharmaceuticals s.r.o. S&D Pharma CZ, spol. s r.o.
-
The medicine is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis. It helps with symptoms such as: runny nose, postnasal drip, sneezing, itching, and nasal congestion.
Form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 0.137 mg fluticasone propionate 0.05 mg ATC: R01AD58
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to prevent breathing problems occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 mcg fluticasone propionate 50 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent the occurrence of shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 mcg fluticasone propionate 125 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 mcg fluticasone propionate 250 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used to prevent asthma attacks in adults and children over 16 years of age and for the treatment of symptoms of chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation in hard capsule
Active substance Dosage fluticasone propionate 0.125 mg ATC: R03BA05
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to prevent asthma attacks in adults and children over 16 years of age, and to treat the symptoms of chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation in hard capsule
Active substance Dosage fluticasone propionate 0.25 mg ATC: R03BA05
Manufacturer: Adamed Pharma S.A.
-
The medicine helps to prevent and treat bronchial asthma attacks in adults and children over 16 years of age who require regular treatment. It acts anti-inflammatorily by reducing swelling and irritation in the lungs. It is important to know that it is not intended to interrupt a sudden asthma attack with shortness of breath.
Form: suspension for nebulization
Active substance Dosage fluticasone propionate 0,5 mg/2 ml ATC: R03BA05
Manufacturer: Adamed Pharma S.A.
-
The medicine helps to prevent and treat bronchial asthma attacks in adults and children over 16 years of age who require regular treatment. It works by reducing swelling and irritation in the lungs and exhibits anti-inflammatory effects. However, it is not intended to interrupt a sudden asthma attack accompanied by shortness of breath.
Form: suspension for nebulization
Active substance Dosage fluticasone propionate 2 mg/2 ml ATC: R03BA05
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD). It helps maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.25 mg ATC: R03AK06
Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.5 mg ATC: R03AK06
Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
-
The medicine is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis. It helps with runny nose, sneezing, itching, and the sensation of nasal congestion.
Form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 0.137 mg fluticasone propionate 0.05 mg ATC: R01AD58
Manufacturer: Farmaclair FARMEA
-
It is used to relieve the symptoms of moderate or severe seasonal and perennial allergic rhinitis. It helps with runny nose, sneezing, itching, and nasal congestion.
Form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 0.137 mg fluticasone propionate 0.05 mg ATC: R01AD58
Manufacturer: Farmaclair FARMEA
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disturbances occurring in asthma.
Form: powder for inhalation, divided
Active substance Dosage salmeterol 0.05 mg/dose fluticasone propionate 0.1 mg/dose ATC: R03AK06
Manufacturer: Oy Medfiles Ltd., Oy Medfiles Ltd., PharmaTan Kft.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma.
Form: powder for inhalation, divided
Active substance Dosage salmeterol 0.05 mg fluticasone propionate 0,250 mg ATC: R03AK06
Manufacturer: Oy Medfiles Ltd., Oy Medfiles Ltd., PharmaTan Kft.
-
This medicine is used in adults and adolescents over 12 years of age to prevent breathing problems occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open, reduces lung swelling and irritation, and prevents shortness of breath and wheezing.
Form: powder for inhalation, divided
Active substance Dosage salmeterol 50 micrograms fluticasone propionate 500 micrograms ATC: R03AK06
Manufacturer: Oy Medfiles Ltd., Oy Medfiles Ltd., PharmaTan Kft.
-
This medicine is used in adults for the symptomatic treatment of allergic rhinitis. It helps relieve symptoms caused by plant pollen (hay fever) or other airborne allergens, such as dust mites, mold spores, or animal dander. It acts on sneezing, itching and watering of the eyes, nasal discharge, and nasal congestion.
Form: spray, nasal suspension
Active substance Dosage fluticasone propionate No input provided ATC: R01AD08
Manufacturer: Glaxo Wellcome S.A. Haleon Germany GmbH
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage salmeterol No input provided fluticasone propionate No input provided ATC: R03AK06
Manufacturer: Orion Corporation
-
This medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage salmeterol No input provided fluticasone propionate No input provided ATC: R03AK06
Manufacturer: Orion Corporation
-
The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). In the case of COPD, it also helps to reduce the number of symptom exacerbations.
Form: powder for inhalation
Active substance Dosage fluticasone propionate No input provided salmeterol 50 mcg ATC: R03AK06
Manufacturer: Celon Pharma Sp. z o.o.
-
Salmex is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). In a dose of 500 μg + 50 μg, it also helps to reduce the number of COPD symptom exacerbations.
Form: powder for inhalation
Active substance Dosage fluticasone propionate No input provided salmeterol 50 mcg ATC: R03AK06
Manufacturer: Celon Pharma Sp. z o.o.
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). In a dose of 500 μg + 50 μg, it also helps to reduce the number of COPD symptom exacerbations.
Form: powder for inhalation
Active substance Dosage fluticasone propionate No input provided salmeterol 50 mcg ATC: R03AK06
Manufacturer: Celon Pharma Sp. z o.o.
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to maintain airway patency and reduces lung swelling and irritation.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg/dose inh. salmeterol xinafoate 50 mcg/dose inh. ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis. It helps with symptoms such as: runny nose, postnasal drip, sneezing, itching, and a feeling of nasal congestion.
Form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 0.137 mg fluticasone propionate 0.05 mg ATC: R01AD58
Manufacturer: Farmaclair FARMEA
-
The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 0.0725 mg/1 dose fluticasone propionate 0.25 mg/1 dose ATC: R03AK06
Manufacturer: ELPEN Pharmaceutical Co. Inc.
-
The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 0.0725 mg/1 dose fluticasone propionate 0.5 mg/1 dose ATC: R03AK06
Manufacturer: ELPEN Pharmaceutical Co. Inc.
-
It is used to relieve moderate to severe symptoms of seasonal and perennial allergic rhinitis (e.g., caused by pollen, dust mites, pet dander). It helps with runny nose, sneezing, itching, and nasal congestion.
Form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 0.137 mg fluticasone propionate 0.05 mg ATC: R01AD58
Manufacturer: Teva Czech Industries s.r.o.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 micrograms/inhalation dose fluticasone propionate 50 micrograms/inhalation dose ATC: R03AK06
Manufacturer: Genetic S.p.A
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 micrograms/inhalation dose fluticasone propionate 125 micrograms/dose inhalation ATC: R03AK06
Manufacturer: Genetic S.p.A
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol 25 micrograms/inhalation dose fluticasone propionate 250 micrograms/dose inhalation ATC: R03AK06
Manufacturer: Genetic S.p.A